Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.

× No keyword cloud information.

41 in total

1. Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells.

Authors: G K Huber; P Fong; E S Concepcion; T F Davies
Journal: J Clin Endocrinol Metab Date: 1991-06 Impact factor: 5.958

2. Follow-up of patients with thyroid carcinoma.

Authors: R D Utiger
Journal: N Engl J Med Date: 1997-09-25 Impact factor: 91.245

3. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

Authors: P W Ladenson; L E Braverman; E L Mazzaferri; F Brucker-Davis; D S Cooper; J R Garber; F E Wondisford; T F Davies; L J DeGroot; G H Daniels; D S Ross; B D Weintraub
Journal: N Engl J Med Date: 1997-09-25 Impact factor: 91.245

Review 4. Thyroid cancer: a lethal endocrine neoplasm.

Authors: J Robbins; M J Merino; J D Boice; E Ron; K B Ain; H R Alexander; J A Norton; J Reynolds
Journal: Ann Intern Med Date: 1991-07-15 Impact factor: 25.391

Review 5. An overview of the management of papillary and follicular thyroid carcinoma.

Authors: E L Mazzaferri
Journal: Thyroid Date: 1999-05 Impact factor: 6.568

6. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults.

Authors: C A Welch Dinauer; R M Tuttle; D K Robie; D R McClellan; R L Svec; C Adair; G L Francis
Journal: Clin Endocrinol (Oxf) Date: 1998-11 Impact factor: 3.478

7. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients.

Authors: M Schlumberger; F De Vathaire; J P Travagli; G Vassal; J Lemerle; C Parmentier; M Tubiana
Journal: J Clin Endocrinol Metab Date: 1987-12 Impact factor: 5.958

8. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors: E L Mazzaferri; S M Jhiang
Journal: Am J Med Date: 1994-11 Impact factor: 4.965

9. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer.

Authors: H R Maxon; S R Thomas; V S Hertzberg; J G Kereiakes; I W Chen; M I Sperling; E L Saenger
Journal: N Engl J Med Date: 1983-10-20 Impact factor: 91.245

10. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.

Authors: M D Ringel; P W Ladenson; M A Levine
Journal: J Clin Endocrinol Metab Date: 1998-12 Impact factor: 5.958

1 in total

1. Type 2 diabetes mellitus is more prevalent among patients with thyroid carcinoma and influences overall survival: a propensity score matching analysis.

Authors: Tao Jiang; Guoliang Qiao; Xiao Zheng; Zhen Wen; Dongxue Zhang
Journal: Oncotarget Date: 2017-10-31

1 in total